IBEX LTD (IBEX) Stock Fundamental Analysis
USA - NASDAQ:IBEX - BMG4690M1010 - Common Stock
37.68 USD
+0.29 (+0.78%)
Taking everything into account, IBEX scores 7 out of 10 in our fundamental rating. IBEX was compared to 86 industry peers in the IT Services industry. IBEX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. An interesting combination arises when we look at growth and value: IBEX is growing strongly while it also seems undervalued. With these ratings, IBEX could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
IBEX had positive earnings in the past year.
IBEX had a positive operating cash flow in the past year.
IBEX had positive earnings in each of the past 5 years.
Each year in the past 5 years IBEX had a positive operating cash flow.
1.2 Ratios
IBEX has a better Return On Assets (13.49%) than 93.02% of its industry peers.
IBEX's Return On Equity of 27.45% is amongst the best of the industry. IBEX outperforms 90.70% of its industry peers.
IBEX has a better Return On Invested Capital (20.43%) than 93.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROIC | 20.43% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IBEX's Profit Margin of 6.60% is fine compared to the rest of the industry. IBEX outperforms 69.77% of its industry peers.
In the last couple of years the Profit Margin of IBEX has grown nicely.
IBEX's Operating Margin of 8.71% is fine compared to the rest of the industry. IBEX outperforms 63.95% of its industry peers.
IBEX's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 30.91%, IBEX perfoms like the industry average, outperforming 41.86% of the companies in the same industry.
IBEX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
IBEX has an Altman-Z score of 5.20. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of IBEX (5.20) is better than 72.09% of its industry peers.
IBEX has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
IBEX's Debt to FCF ratio of 0.06 is amongst the best of the industry. IBEX outperforms 94.19% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that IBEX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, IBEX belongs to the top of the industry, outperforming 82.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 5.2 |
ROIC/WACC2.21
WACC9.24%
2.3 Liquidity
IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.82, IBEX perfoms like the industry average, outperforming 55.81% of the companies in the same industry.
IBEX has a Quick Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.82, IBEX is in line with its industry, outperforming 58.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.08%, which is quite impressive.
IBEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.04% yearly.
The Revenue has grown by 9.78% in the past year. This is quite good.
IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.62% yearly.
EPS 1Y (TTM)32.08%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%50%
Revenue 1Y (TTM)9.78%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%18.15%
3.2 Future
IBEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.11% yearly.
Based on estimates for the next years, IBEX will show a quite strong growth in Revenue. The Revenue will grow by 8.28% on average per year.
EPS Next Y16.57%
EPS Next 2Y12.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IBEX is valuated correctly with a Price/Earnings ratio of 13.46.
82.56% of the companies in the same industry are more expensive than IBEX, based on the Price/Earnings ratio.
IBEX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.83.
Based on the Price/Forward Earnings ratio of 11.54, the valuation of IBEX can be described as reasonable.
Based on the Price/Forward Earnings ratio, IBEX is valued cheaply inside the industry as 81.40% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.82. IBEX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 11.54 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 86.05% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBEX indicates a somewhat cheap valuation: IBEX is cheaper than 69.77% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.39 | ||
| EV/EBITDA | 7.35 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBEX has a very decent profitability rating, which may justify a higher PE ratio.
IBEX's earnings are expected to grow with 12.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.81
PEG (5Y)0.33
EPS Next 2Y12.11%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for IBEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:IBEX (10/24/2025, 9:40:19 AM)
37.68
+0.29 (+0.78%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners94.9%
Inst Owner Change0.22%
Ins Owners8.95%
Ins Owner Change-3.95%
Market Cap501.90M
Revenue(TTM)558.27M
Net Income(TTM)36.86M
Analysts45.71
Price Target39.27 (4.22%)
Short Float %1.42%
Short Ratio1.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.37%
Min EPS beat(2)10.89%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)13.65%
Min EPS beat(4)7.33%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)11.1%
EPS beat(12)10
Avg EPS beat(12)14.9%
EPS beat(16)11
Avg EPS beat(16)6.92%
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)5.12%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.42%
Min Revenue beat(4)1.58%
Max Revenue beat(4)8.52%
Revenue beat(8)4
Avg Revenue beat(8)1.31%
Revenue beat(12)4
Avg Revenue beat(12)-0.58%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)0%
PT rev (3m)26.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.55%
EPS NY rev (1m)4.4%
EPS NY rev (3m)4.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 11.54 | ||
| P/S | 0.9 | ||
| P/FCF | 18.39 | ||
| P/OCF | 10.99 | ||
| P/B | 3.74 | ||
| P/tB | 4.11 | ||
| EV/EBITDA | 7.35 |
EPS(TTM)2.8
EY7.43%
EPS(NY)3.26
Fwd EY8.66%
FCF(TTM)2.05
FCFY5.44%
OCF(TTM)3.43
OCFY9.1%
SpS41.91
BVpS10.08
TBVpS9.16
PEG (NY)0.81
PEG (5Y)0.33
Graham Number25.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROCE | 25.17% | ||
| ROIC | 20.43% | ||
| ROICexc | 22.19% | ||
| ROICexgc | 23.83% | ||
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% | ||
| FCFM | 4.89% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 106.63% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 29.77 | ||
| Cash Conversion | 69.33% | ||
| Profit Quality | 74.04% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.2 |
F-Score8
WACC9.24%
ROIC/WACC2.21
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.08%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%50%
EPS Next Y16.57%
EPS Next 2Y12.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.78%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%18.15%
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.91%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year66.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.92%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y27.21%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
Can you provide the valuation status for IBEX LTD?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
Can you provide the financial health for IBEX stock?
The financial health rating of IBEX LTD (IBEX) is 7 / 10.
Can you provide the expected EPS growth for IBEX stock?
The Earnings per Share (EPS) of IBEX LTD (IBEX) is expected to grow by 16.57% in the next year.